Graphus vs Tessian Guardian comparison

Graphus provides advanced email security focused on protecting businesses from cyber threats, including phishing attacks. It integrates seamlessly into existing systems, ensuring that security measures are robust and effective while maintaining ease of use.

Designed for businesses seeking heightened protection against email threats, Graphus utilizes AI-driven threat prevention tools that accurately identify and neutralize phishing attempts. Its intuitive integration with email systems leverages user identity graphs and machine learning to safeguard sensitive information. Continuous development ensures the platform adapts to evolving threats, maintaining a leading position in cybersecurity. While users appreciate its reliability, there's potential for enhancements in customization options to better serve diverse security landscapes.

• AI-Powered Protection: Leverages artificial intelligence to detect and block potential threats effectively.
• EmployeeShield: Provides real-time alerts when suspicious emails are detected, educating users on risks.
• Phish911: Facilitates quick reporting and isolation of suspected phishing emails by users.
• Dashboard Analytics: Offers detailed insights into threat patterns and overall email security status.

• Enhanced Security: Reduces the risk of phishing attacks with advanced threat detection.
• Increased Efficiency: Automates threat analysis, allowing IT teams to focus on strategic tasks.
• Cost Savings: Decreases potential cyberattack-related expenses by preventing breaches.
• Improved User Awareness: Educates employees about email threats, fostering a culture of security.

Graphus is well-suited for finance, education, and healthcare industries, where sensitive data protection is critical. Financial institutions utilize its robust detection features to secure client data, educational sectors benefit from its ease of deployment in varied environments, while healthcare organizations rely on advanced security to comply with regulations like HIPAA.